Kite Pharma wasn’t expecting a regulatory decision for its non-Hodgkin lymphoma treatment until November, but this week, the company got the FDA’s O.K.
The conventional wisdom about Silicon Valley is that it’s a playground for the underdogs, a fertile ground for young entrepreneurs building startups that are going to “change the world.”
Instead, the Bay Area—while, yes, still home to thirsty young entrepreneurs—is increasingly... Read more »
In advance of an anticipated Senate hearing on drug prices, President Donald Trump once again denounced drug companies as “getting away with murder.” The first time he did so, using the same phrase just before his inauguration, the markets shuddered.... Read more »
E-mail is ubiquitous to modern corporate life, but despite its popularity, it’s not always an effective way to communicate. Between automated inbox filters that barely work, productivity-killing overload, and suspicious communications sent by malicious actors, e-mail can be a potential minefield... Read more »
OrthoPediatrics is making its stock market debut today in a $52 million IPO that will support the company’s lineup of medical devices developed specifically for children.
In mid-October, eleven college students will be flying to California for an opportunity that would be the envy of any Ivy League MBA candidate—they’ll meet the venture capital firm partners who will personally mentor them throughout the school year.
The students—all... Read more »
Steve Case, venture capitalist, author, and co-founder of AOL, is preparing to hit the road this week on his sixth Rise of the Rest tour, where he travels to emerging innovation hubs in search of investment-worthy tech startups and to highlight... Read more »
The Indiana University School of Medicine is the largest in the country, producing more doctors each year than any other American university. IU is also home to an estimated 900 scientist-researchers.
What IU didn’t have, until recently, was a central place... Read more »
AltspaceVR, one of the forerunners of shared social experiences in virtual reality spaces, has been saved from extinction by Microsoft, which announced Tuesday that it is acquiring the four-year-old company.
The Redwood City, CA-based startup had sounded its own death knell... Read more »
Four months after two Endocyte drug candidates stumbled in early-stage studies, sparking a corporate shakeup, the company has signed a deal landing an experimental prostate cancer treatment that it says is ready for Phase 3 clinical trials.
West Lafayette, IN-based Endocyte... Read more »
Another high-profile attempt to produce an Alzheimer’s treatment has failed.
An unusual biotech company called Axovant Sciences (NASDAQ: AXON) reported today that its drug intepirdine did not show a meaningful difference between the patients taking a combination of intepirdine and... Read more »
President Donald Trump, who has had a rocky relationship with tech companies during his short administration so far, announced an education initiative Monday that apparently met with their approval.
In a White House ceremony, Trump directed his education secretary to allocate... Read more »
[Updated 9/25/17, 1:55 p.m. Clarified 9/27/17, 10:01 a.m. See below.] Immigration policy has always been important to the tech industry, but this year is different. Under a steady barrage of nationalist, anti-immigrant policies promulgated by the Trump administration, the... Read more »
Founder, Launch Fishers and Launch Indiana
President and CEO, Recovery Force
Assoc Professor, Strategy & Entrepreneurship, Indiana University
President & CEO, Indiana Biosciences Research Institute
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Co-founder and partner at High Alpha
Serial Entrepreneur and Investor
President and CEO of the Central Indiana Corporate Partnership
President and CEO, Lumina Foundation
President and CEO of the Indiana University Research & Technology Corporation
CEO of ChaCha